Lam Dong Pharmaceutical JSC
VN:LDP
Balance Sheet
Balance Sheet Decomposition
Lam Dong Pharmaceutical JSC
Lam Dong Pharmaceutical JSC
Balance Sheet
Lam Dong Pharmaceutical JSC
| Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
4 829
|
5 189
|
8 631
|
14 367
|
24 278
|
11 777
|
4 180
|
1 992
|
6 805
|
10 719
|
10 386
|
28 283
|
19 163
|
65 159
|
16 619
|
16 205
|
11 451
|
18 614
|
|
| Cash |
4 829
|
5 189
|
8 631
|
14 367
|
24 278
|
11 777
|
4 180
|
1 992
|
6 805
|
10 719
|
10 386
|
10 283
|
3 163
|
12 159
|
9 619
|
7 205
|
4 451
|
11 614
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
18 000
|
16 000
|
53 000
|
7 000
|
9 000
|
7 000
|
7 000
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 788
|
3 121
|
4 692
|
2 000
|
|
| Total Receivables |
9 695
|
15 262
|
27 983
|
31 939
|
38 357
|
47 899
|
59 342
|
63 847
|
53 278
|
48 812
|
40 716
|
54 267
|
34 237
|
23 719
|
32 218
|
32 421
|
37 725
|
64 146
|
|
| Accounts Receivables |
9 346
|
14 600
|
25 864
|
29 291
|
35 810
|
44 277
|
56 339
|
60 530
|
50 889
|
47 358
|
38 088
|
53 293
|
33 579
|
23 286
|
21 415
|
21 205
|
26 917
|
53 230
|
|
| Other Receivables |
349
|
662
|
2 119
|
2 648
|
2 547
|
3 622
|
3 003
|
3 317
|
2 389
|
1 454
|
2 628
|
974
|
658
|
433
|
10 803
|
11 216
|
10 808
|
10 916
|
|
| Inventory |
30 140
|
37 398
|
54 549
|
68 771
|
69 120
|
80 901
|
70 709
|
96 351
|
131 096
|
116 880
|
112 228
|
94 621
|
76 153
|
54 575
|
55 952
|
37 751
|
48 962
|
55 422
|
|
| Other Current Assets |
887
|
606
|
1 160
|
1 572
|
328
|
649
|
269
|
515
|
2 594
|
4 115
|
9 469
|
1 558
|
523
|
831
|
52 415
|
50 494
|
53 902
|
119 761
|
|
| Total Current Assets |
45 552
|
58 454
|
92 324
|
116 649
|
132 082
|
141 226
|
134 499
|
162 705
|
193 773
|
180 526
|
172 799
|
178 729
|
130 076
|
144 283
|
158 993
|
139 993
|
156 733
|
259 943
|
|
| PP&E Net |
24 640
|
23 314
|
26 414
|
25 979
|
27 130
|
37 320
|
67 988
|
77 883
|
75 829
|
83 180
|
80 166
|
90 877
|
76 290
|
60 718
|
55 742
|
46 329
|
42 555
|
38 655
|
|
| PP&E Gross |
24 640
|
23 314
|
26 414
|
25 979
|
27 130
|
37 320
|
67 988
|
77 883
|
75 829
|
83 180
|
80 166
|
90 877
|
76 290
|
60 718
|
55 742
|
46 329
|
42 555
|
38 655
|
|
| Accumulated Depreciation |
10 286
|
13 468
|
16 817
|
20 126
|
24 077
|
26 757
|
31 536
|
38 834
|
47 560
|
57 167
|
67 789
|
77 431
|
88 521
|
67 427
|
74 911
|
78 745
|
84 615
|
64 755
|
|
| Intangible Assets |
406
|
1 015
|
1 414
|
3 209
|
3 080
|
4 621
|
4 474
|
4 322
|
4 745
|
4 564
|
4 762
|
4 260
|
4 273
|
740
|
492
|
229
|
69
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
12
|
15
|
15
|
35
|
269
|
204
|
228
|
1 076
|
215
|
0
|
162
|
489
|
|
| Long-Term Investments |
995
|
950
|
5
|
860
|
815
|
2 063
|
1 973
|
1 884
|
1 794
|
1 705
|
1 615
|
500
|
450
|
2 588
|
2 479
|
2 370
|
2 271
|
2 162
|
|
| Other Long-Term Assets |
150
|
38
|
365
|
71
|
154
|
842
|
3 105
|
5 519
|
4 877
|
6 033
|
8 150
|
10 234
|
6 289
|
6 515
|
10 470
|
5 851
|
5 367
|
6 655
|
|
| Total Assets |
71 743
N/A
|
83 772
+17%
|
120 522
+44%
|
146 768
+22%
|
163 262
+11%
|
186 072
+14%
|
212 052
+14%
|
252 327
+19%
|
281 033
+11%
|
276 043
-2%
|
267 761
-3%
|
284 804
+6%
|
217 607
-24%
|
215 921
-1%
|
228 391
+6%
|
194 773
-15%
|
207 157
+6%
|
307 903
+49%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
30 943
|
27 783
|
52 877
|
60 913
|
70 293
|
84 633
|
90 781
|
116 043
|
123 888
|
87 027
|
101 862
|
59 856
|
40 234
|
13 964
|
31 835
|
23 549
|
31 545
|
30 970
|
|
| Accrued Liabilities |
7 232
|
5 483
|
4 323
|
8 697
|
11 692
|
12 657
|
8 471
|
1 988
|
3 637
|
2 956
|
5 238
|
14 088
|
5 573
|
3 345
|
7 216
|
8 334
|
15 735
|
19 918
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
49 210
|
84 796
|
40 500
|
27 372
|
37 331
|
35 148
|
27 206
|
30 464
|
|
| Current Portion of Long-Term Debt |
1 000
|
7 900
|
5 098
|
0
|
0
|
0
|
5 383
|
23 965
|
39 825
|
52 609
|
7 285
|
5 883
|
3 723
|
2 588
|
32 967
|
30 812
|
27 820
|
26 510
|
|
| Other Current Liabilities |
1 455
|
3 968
|
5 695
|
6 628
|
3 493
|
4 466
|
3 759
|
3 062
|
3 124
|
4 000
|
3 245
|
11 004
|
4 215
|
11 214
|
4 261
|
2 844
|
3 797
|
7 923
|
|
| Total Current Liabilities |
40 629
|
45 135
|
67 993
|
76 238
|
85 478
|
101 756
|
108 393
|
145 058
|
170 475
|
146 592
|
166 839
|
175 627
|
94 245
|
58 483
|
113 609
|
100 687
|
106 103
|
115 785
|
|
| Long-Term Debt |
4 114
|
0
|
0
|
0
|
0
|
0
|
13 981
|
12 625
|
7 436
|
15 020
|
9 498
|
9 980
|
5 072
|
2 339
|
592
|
0
|
0
|
0
|
|
| Other Liabilities |
1 789
|
1 655
|
1 698
|
3 867
|
4 332
|
5 612
|
4 772
|
5 272
|
6 870
|
7 203
|
6 327
|
5 519
|
1 881
|
1 720
|
1 720
|
1 720
|
1 770
|
1 780
|
|
| Total Liabilities |
46 532
N/A
|
46 790
+1%
|
69 691
+49%
|
80 105
+15%
|
89 810
+12%
|
107 368
+20%
|
127 147
+18%
|
162 955
+28%
|
184 781
+13%
|
168 815
-9%
|
182 664
+8%
|
191 127
+5%
|
101 198
-47%
|
62 541
-38%
|
115 921
+85%
|
102 407
-12%
|
107 873
+5%
|
117 565
+9%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
17 000
|
17 000
|
17 000
|
34 000
|
34 000
|
34 000
|
34 000
|
34 000
|
67 999
|
78 300
|
78 300
|
78 300
|
127 032
|
127 032
|
127 032
|
127 032
|
127 032
|
187 282
|
|
| Retained Earnings |
0
|
12 427
|
16 367
|
22 395
|
19 683
|
18 007
|
18 582
|
17 699
|
19 767
|
14 626
|
7 580
|
368
|
25 602
|
12 268
|
38 909
|
59 014
|
52 095
|
3 057
|
|
| Additional Paid In Capital |
5 419
|
5 419
|
5 419
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
2 793
|
2 136
|
12 045
|
10 269
|
19 769
|
26 698
|
32 324
|
37 674
|
8 487
|
14 303
|
14 377
|
15 010
|
14 980
|
14 080
|
24 348
|
24 348
|
24 348
|
0
|
|
| Total Equity |
25 212
N/A
|
36 982
+47%
|
50 831
+37%
|
66 663
+31%
|
73 452
+10%
|
78 704
+7%
|
84 905
+8%
|
89 372
+5%
|
96 253
+8%
|
107 228
+11%
|
85 097
-21%
|
93 677
+10%
|
116 409
+24%
|
153 380
+32%
|
112 470
-27%
|
92 366
-18%
|
99 284
+7%
|
190 338
+92%
|
|
| Total Liabilities & Equity |
71 743
N/A
|
83 772
+17%
|
120 522
+44%
|
146 768
+22%
|
163 262
+11%
|
186 072
+14%
|
212 052
+14%
|
252 327
+19%
|
281 033
+11%
|
276 043
-2%
|
267 761
-3%
|
284 804
+6%
|
217 607
-24%
|
215 921
-1%
|
228 391
+6%
|
194 773
-15%
|
207 157
+6%
|
307 903
+49%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
8
|
8
|
8
|
8
|
8
|
8
|
8
|
10
|
10
|
10
|
10
|
10
|
13
|
13
|
13
|
13
|
13
|
19
|
|